People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Biotechnology, Construction
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pacific Diabetes Technologies, Inc. | — | Biotechnology | Seed | $9.0M | $8.1M | 2025 |
| IVDiagnostics, Inc. | — | Biotechnology | Seed | $5.5M | $63.4M | 2010 |
| Associated General Contractors of Colorado, Building Chapter Inc. | — | Construction | Pre-Seed | $500K | $4.7M | 2012 |
Mark Huber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Huber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Thomas | 1 | 10 |
| Jim Brown | 1 | 6 |
| Christopher Marsh | 1 | 4 |
| Seth Burgett | 1 | 3 |
| Wei He | 1 | 3 |
| Kenneth Ward | 1 | 2 |
| Ken Ward | 1 | 2 |
| Tom Szczepanski | 1 | 2 |
| Frank Szczepanski | 1 | 2 |
| Craig Clark | 1 | 2 |
| Yobie Benjamin | 1 | 1 |
| Peter Eckenberg | 1 | 1 |
| Darlene Kittredge | 1 | 1 |
| Thomas Seidel | 1 | 1 |
| Joerg Schreiber | 1 | 1 |
| Edward La Cava | 1 | 1 |
| Ed La Cava | 1 | 1 |
| Brett Dines | 1 | 1 |
| Hank Wuh | 1 | 1 |
| Thomas Seidl | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.